Table 2.
Hematological parameters of study population (mean ± SEM).
| Parameters | Group | Before Treatment | After Treatment |
|---|---|---|---|
| WBC × 103/µL | Placebo | 6.22 ± 0.34 | 5.81 ± 0.27 |
| G1 | 6.36 ± 0.45 | 6.25 ± 0.47 | |
| G2 | 5.90 ± 0.20 | 6.20 ± 0.30 | |
| RBC × 106/µL | Placebo | 4.94 ± 0.05 | 4.91 ± 0.05 |
| G1 | 5.03 ± 0.10 | 4.92 ± 0.07 | |
| G2 | 4.86 ± 0.08 | 4.91 ± 0.08 | |
| Hemoglobin [g/dL] | Placebo | 14.51 ± 0.38 | 14.48 ± 0.27 |
| G1 | 15.25 ± 0.29 | 14.97 ± 0.29 | |
| G2 | 14.71 ± 0.27 | 14.86 ± 0.30 | |
| Hematocrit [%] | Placebo | 42.84 ± 0.87 | 42.69 ± 0.52 |
| G1 | 44.18 ± 0.68 | 43.37 ± 0.77 | |
| G2 | 42.60 ± 0.72 | 43.08 ± 0.73 | |
| Lymphocytes × 103/µL | Placebo | 1.97 ± 0.14 | 1.93 ± 0.13 |
| G1 | 1.95 ± 0.12 | 1.93 ± 0.11 | |
| G2 | 1.83 ± 0.10 | 2.08 ± 0.09 | |
| Platelets × 103/µL | Placebo | 204.19 ± 9.5 | 199.94 ± 8.07 |
| G1 | 213.23 ± 16.7 | 227.57 ± 19.0 | |
| G2 | 236.65 ± 13.2 * | 250.24 ± 13.6 * |
* Statistically significant differences p < 0.05.